Register | Log in | FAQ      [?] 

Lancet Oncology

Articles from the last few issues of Lancet Oncology © Elsevier
  • Orthopaedic revolution
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 69-69.
    by The L Oncology
  • Fragile sites and cancer genes on the short arm of chromosome 8
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 77-77.
    by NC Popescu
  • Author's reply
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 77-77.
    by D Birnbaum, M Chaffanet
  • HRPT2 and parathyroid cancer
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 78-78.
    by DJ Marsh, H Morreau, BT Teh
  • Circulating tumour cells in breast cancer
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 79-88.
    by A Ring, IE Smith, M Dowsett
  • Genomics-based hypothesis generation: a novel approach to unravelling drug resistance in brain tumours?
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 89-100.
    by M Bredel, C Bredel, BI Sikic
  • Small-animal imaging of tumour proliferation with PET
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 100-100.
    by H Barthel, P Price, EO Aboagye
  • Active surveillance: towards a new paradigm in the management of early prostate cancer
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 101-106.
    by C Parker
  • Uncommon primary mediastinal tumours
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 107-118.
    by P Macchiarini, H Ostertag
  • Explanatory models of and attitudes towards cancer in different cultures
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 119-124.
    by S Dein
  • Haploidentical, non-myeloablative stem-cell transplantation for advanced renal-cell carcinoma
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 125-126.
    by M Satoh, K Miyamura, M Yamada, S Ishidoya, RW Childs, Y Arai
  • Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 127-128.
    by A Liso, E Tiacci, R Binazzi, K Pulford, R Benedetti, A Carotti, F Aversa, B Falini
  • Clinical trials with moving targets: a commentary on a non-inferiority trial in testicular cancer
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 129-132.
    by M Cullen, S Stenning
  • Expression Profiling of Human Tumors: Diagnostic and Research Applications
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 133-133.
    by RH Datar, RJ Cote
  • Accidents will happen
    Lancet Oncology, Vol. 5, No. 2. (1 February 2004), pp. 134-134.
    by JA Lee
    • Note: You may cite this page as: http://www.citeulike.org/journal/els-14702045

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.